Unknown

Dataset Information

0

Left Atrial Appendages Occlusion: Current Status and Prospective.


ABSTRACT: Stroke continues to be a major cause of morbidity and mortality in atrial fibrillation (AF) patients. Oral anticoagulation (OAC) provides protection against stroke and peripheral embolization in AF but significant proportion of patients could not be started on anticoagulation because of bleeding complications. Left atrial appendage harbors clot in about 90% of nonvalvular AF. The advent of left atrial appendage occlusion (LAAO) techniques has provided these patients with alternative to OAC for stroke prophylaxis. Multiple LAAO devices are currently available with Watchman and Amulet being the most commonly used in clinical practice. Randomized studies are available for Watchman device only. Data on Amplatzer Cardiac Plug, Amulet and Lariat devices are limited by the paucity of randomized data. Long-term data on different LAAO techniques are showing promising results. Device related thrombosis continues to be a serious complication associated with LAAO. Future studies should look into comparative effectiveness between different LAAO techniques, optimal patient selection, risk of complications, and anticoagulant treatment after LAAO. This article aims to provide current available evidence on efficacy and safety of different LAAO devices and future prospective.

SUBMITTER: Sharma SP 

PROVIDER: S-EPMC6072669 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Left Atrial Appendages Occlusion: Current Status and Prospective.

Sharma Sharan Prakash SP   Park Peter P   Lakkireddy Dhanunjaya D  

Korean circulation journal 20180801 8


Stroke continues to be a major cause of morbidity and mortality in atrial fibrillation (AF) patients. Oral anticoagulation (OAC) provides protection against stroke and peripheral embolization in AF but significant proportion of patients could not be started on anticoagulation because of bleeding complications. Left atrial appendage harbors clot in about 90% of nonvalvular AF. The advent of left atrial appendage occlusion (LAAO) techniques has provided these patients with alternative to OAC for s  ...[more]

Similar Datasets

| S-EPMC10707282 | biostudies-literature
| S-EPMC9909459 | biostudies-literature
| S-EPMC5153132 | biostudies-literature
| S-EPMC7854490 | biostudies-literature
| S-EPMC7205034 | biostudies-literature
| S-EPMC8445086 | biostudies-literature
| S-EPMC6490608 | biostudies-literature
| S-EPMC6302031 | biostudies-other
| S-EPMC3595246 | biostudies-literature
| S-EPMC6732415 | biostudies-literature